Metropolis Healthcare Limited has informed the Exchange regarding Change in Auditors of the company.
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare Limited's Board meeting on May 13, 2026 approved multiple items: (1) Audited FY2026 standalone net profit of Rs 15,748.33 lakhs (up 26% from Rs 12,479.60 lakhs) and consolidated net profit of Rs 19,118.20 lakhs, with B S R & Co. LLP giving unmodified audit opinions; (2) Declared 2nd interim dividend of Rs 1 per share (record date May 19, 2026); (3) Appointed Deloitte Haskins & Sells LLP as new statutory auditors for 5 years from the 26th AGM, replacing retiring auditors B S R & Co. LLP who completed their second term; (4) Dr. Nilesh Shah transitioned from President - Internal Assurance to advisory role effective May 14, 2026, and ceased to be classified as Senior Management Personnel from May 13, 2026.
The auditor change appears routine as B S R & Co. LLP completes its term, and Deloitte is a Big 4 firm, which may bring fresh perspective. The KMP transition (Dr. Nilesh Shah) could signal internal restructuring. Strong profit growth of ~26% YoY and shareholder returns through dividends are positive signals.